Three-layer sharp compound film for improving fracture healing

Abstract

The invention provides a three-layer pointed composite film for improving fracture healing, which includes an elastic layer, a drug layer, and a guiding layer from the inside to the outside, the elastic layer is a dense degradable or non-degradable biofilm, and the drug layer encapsulates There is a drug slow-release system that can promote bone healing. The material is a degradable or absorbable material that is biocompatible with human bone. The material of the guide layer is biocompatible or non-degradable. It is a porous and loose substance that absorbs or does not absorb. The biological microstructure membrane is a long strip-shaped folded structure with a "V"-shaped cross section. The inner part is an elastic layer, and the outermost layer is a drug layer. The "V"-shaped The section width to depth ratio is 0.5‑1.5, with the width being the gap between fractured bone surfaces spliced ​​together after fracture surgery.

Description

technical field [0001] The invention relates to a three-layer pointed composite film for improving fracture healing. Background technique [0002] At present, it is a frontier field of medical research to use a biocomposite film containing growth factors / stem cells to stick to the fracture line to enhance the speed and quality of fracture healing. There are blood vessels and bone cells distributed on the inner surface of the fracture line (anastomosis line), and whether the healing is good depends on the growth of blood vessels and bone cells in the fracture line. The reason why biofilm sticking to the surface of fracture anastomosis can increase the quality of fracture healing is that on the one hand, the drugs encapsulated in the biofilm can promote the growth of blood vessels and bone cells in the fracture anastomosis, and on the other hand, the biological The membrane isolates external muscles and other human tissues from the fracture anastomotic line, and prevents the ...

AI Technical Summary

Problems solved by technology

[0004] 1. The biocomposite membrane has a relatively large volume area and a small fracture area, and 2 cannot be effectively fitted and fixed together

[0005] 2. The limitations of the current biocomposite membrane materials and manufacturing process lead to performance indicators such as the degradation rate of the biocomposite membrane and the time for the carried growth factors to release the effective drug concentration (the duration of the effective concentration is the key to the healing quality of the fracture line) Unable to meet clinical needs

Images